Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid cancer, medullary × fluorodopa F 18 × CNS × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1 CNS 1

Conditions

Glioma 10 Glioblastoma 5 Neuroblastoma 3 Recurrence 2 Parkinson Disease 2 Neuroendocrine Tumors 2 Congenital Hyperinsulinism 2 Brain Neoplasms 2 Thyroid cancer, medullary 1 Pheochromocytoma 1 Paraganglioma 1 Oligodendroglioma 1 Lewy Body Disease 1 Insulinoma 1 Gliosarcoma 1 Glioma, Subependymal 1 Ependymoma 1 Carcinoid Tumor 1 Astrocytoma 1

Interventions

fluorodopa F 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available

CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡